Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core
Authors:
- Gustavo Nader MartaGMGustavo Nader Marta
- Tomás Y. T. de SouzaTSTomás Y. T. de Souza
- Alice R. N. de Souza e SilvaASAlice R. N. de Souza e Silva
- Ana Paula A. PereiraAPAna Paula A. Pereira
- David R. Ferreira NetoDNDavid R. Ferreira Neto
- Rie N. AssoRARie N. Asso
- Fabiana A. M. DegrandeFDFabiana A. M. Degrande
- Guilherme Nader-MartaGNGuilherme Nader-Marta
- Maurício F. da SilvaMSMaurício F. da Silva
- Rafael GadiaRGRafael Gadia
- Samir A. HannaSHSamir A. Hanna
- Bernhard HolznerBHBernhard Holzner
Open Access
- 31 August 2021
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 28 (5) , 3373-3383
Abstract
Background: This study aimed to validate the Brazilian version of EORTC CAT Core and compare the Brazilian results with those from the original European EORTC CAT Core validation study. Methods: After validated translation, 168 cancer patients from Brazil receiving radiation therapy with or without chemotherapy was assessed. Translated EORTC CAT Core and all QLQ-C30 items were administered to patients using CHES (Computer-Based Health Evaluation System) before (T0) and after (T1) treatment initiation. The association between QLQ-C30 and CAT scores and ceiling/floor effects were estimated. Based on estimates of relative validity (cross-sectional, known-group differences and changes over time), relative sample-size requirements for CAT compared to QLQ-C30 were estimated. Results: Correlation coefficients between CAT and QLQ-C30 domains ranged from 0.63 to 0.93; except for dyspnoea, all coefficients were >0.82 (corresponding figures were 0.81–0.93 in the European study). On average across domains, floor/ceiling was reduced by 10% using CAT (9% in the European study) corresponding to a relative reduction of 32% (37% in the European study). Analyses of known-group validity and responsiveness indicated that, on average across domains, the sample-size requirements may be reduced by 17% using CAT rather than QLQ-C30, without loss of power (28% in the European study). The Brazilian sample had less symptom/quality of life impairment than the European sample, which likely explains the lower sample-size reduction using CAT when comparing with the European sample. Conclusions: The results in the Brazilian cohort were generally similar to those from the European sample and confirm the validity and usefulness of the EORTC CAT Core.Keywords
This publication has 21 references indexed in Scilit:
- Development of an item bank for computerized adaptive test (CAT) measurement of painQuality of Life Research, 2015
- Development of a lack of appetite item bank for computer-adaptive testing (CAT)Supportive Care in Cancer, 2014
- The EORTC emotional functioning computerized adaptive test: phases I–III of a cross‐cultural item bank developmentPsycho-Oncology, 2013
- The EORTC computer-adaptive tests measuring physical functioning and fatigue exhibited high levels of measurement precision and efficiencyJournal of Clinical Epidemiology, 2013
- Psychometric evaluation of the EORTC computerized adaptive test (CAT) fatigue item poolQuality of Life Research, 2013
- Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patientsHealth and Quality of Life Outcomes, 2011
- Development of computerized adaptive testing (CAT) for the EORTC QLQ-C30 physical functioning dimensionQuality of Life Research, 2010
- Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions – General approach and initial results for physical functioningEuropean Journal of Cancer, 2010
- Quality of life research within the EORTC—the EORTC QLQ-C30European Journal of Cancer, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993